A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

NCT02320773 · clinicaltrials.gov ↗

COMPLETED

Status

863

Enrollment

INDUSTRY

Sponsor class

Conditions

Urgency Incontinence
Urinary Bladder Overactive
Overactive Bladder
Urologic Diseases
Urinary Bladder Diseases

Interventions

DRUG: Betmiga®

Sponsor

Astellas Pharma Europe Ltd.